Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2003
12/11/2003CA2486933A1 Tetrahydropyran derivative
12/11/2003CA2482838A1 Pyrazole compounds and pharmaceutical compositions containing the compound
12/10/2003EP1369419A1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
12/10/2003EP1369418A1 Quinazoline derivatives
12/10/2003EP1368346A1 Substituted benzofuran-2-carboxamides derivatives
12/10/2003EP1368345A1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists
12/10/2003EP1368344A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)
12/10/2003EP1368342A2 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
12/10/2003EP1368340A1 Piperazine derivatives as melanocortin receptor agonists
12/10/2003EP1368325A1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
12/10/2003EP1368324A1 Quinazolines as mmp-13 inhibitors
12/10/2003EP1368323A1 Pyrimidine matrix metalloproteinase inhibitors
12/10/2003EP1368320A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof
12/10/2003EP1368319A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
12/10/2003EP1368314A1 N-4-piperidinyl compounds as ccr5 modulators
12/10/2003EP1368034A1 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
12/10/2003EP1367893A1 Pyridyl pyrimidines for use as pesticides
12/10/2003EP1187829B1 Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
12/10/2003EP1177191B1 Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa
12/10/2003EP0714396B1 Vasocontrictive dihydrobenzopyran derivatives
12/10/2003EP0628064B2 Photochromic naphthopyrans
12/10/2003CN1461298A Compositions and methods of use thereof achiral analogues of CC-1065 and duocarmycins
12/10/2003CN1130403C In situ block copolymer formation during polymerization of vinyl axomatic monomer
12/10/2003CN1130366C Substituted phenylketoenols and preparing method, midbody and their use as pestcides and herbicides
12/10/2003CN1130359C Substituted benzimidazole, its preparation and use as means against parastic protozoa
12/10/2003CN1130358C Imidzzole compounds and preparing method and application thereof
12/10/2003CN1130351C 1,5-benzodiazepine derivatives
12/09/2003US6660866 C10 carbonate substituted taxanes
12/09/2003US6660854 Processes for preparing β-D-ribofuranose derivatives
12/09/2003US6660760 Heterocyclic aromatic compounds useful as growth hormone secretagogues
12/09/2003US6660753 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
12/09/2003US6660752 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
12/09/2003US6660742 Alkylation therapy; anticancer agent
12/09/2003US6660740 Sorbitol dehydrogenase inhibitors
12/09/2003US6660739 Heterocyclic amides as inhibitors of factor Xa
12/09/2003US6660736 MAO-B inhibitors
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/09/2003US6660731 Pyrazole compounds useful as protein kinase inhibitors
12/09/2003CA2189593C Sulphonylaminocarbonyltriazolinones having substituents bonded via oxygen
12/04/2003WO2003099844A2 Protease inhibitors
12/04/2003WO2003099813A1 Novel physiolgically active substances
12/04/2003WO2003099812A1 Phenyl-furan or phenyl-thiophene derivatives, their preparation and their use as medicine
12/04/2003WO2003099810A2 Radiopharmaceuticals for imaging infection and inflammation
12/04/2003WO2003099796A1 Protein kinase inhibitors
12/04/2003WO2003099795A1 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2b and alpha-2c adrenergic receptors
12/04/2003WO2003099787A1 Novel piperidine compound
12/04/2003WO2003099786A2 Aromatic sulfones and their medical use
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099773A1 Ccr9 inhibitors and methods of use thereof
12/04/2003WO2003099765A1 β-ALANINE DERIVATIVE AND USE THEREOF
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003WO2003099266A2 Acetamides and benzamides that are useful in treating sexual dysfunction
12/04/2003WO2003099221A2 Methods for using jnk inhibitors for treating or preventing disease-related wasting
12/04/2003WO2003078626A3 A building block capable of transferring a functional entity
12/04/2003WO2003075921A3 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/04/2003WO2003063794A3 2,4-pyrimidinediamine compounds and their uses
12/04/2003WO2003051860A3 Substituted 2-phenyl benzofurans as estrogenic agents
12/04/2003WO2003027085A3 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors
12/04/2003WO2003020280A3 Compositions and use thereof in the treatment of cancer
12/04/2003WO2003018568A3 Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
12/04/2003WO2002094796A3 Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases
12/04/2003WO2002080846A3 Epothilone derivatives and methods for making and using the same
12/04/2003WO2002073208A3 Anti-epileptogenic agents
12/04/2003WO2002068397A8 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors
12/04/2003WO2002030462A3 Hedgehog antagonists, methods and uses related thereto
12/04/2003US20030225288 Small organic compounds to modulate chemokine receptor activity; treating psoriasis, autoimmune diseases, multiple sclerosis, graft rejection, infectious diseases; anti-allergen, -arthritic, -inflammatory, carcinogenic agents
12/04/2003US20030225283 2-Substituted phenyl,3-polar ring,N-heroaromatic propion-amides, e.g., 1-(2-(3,4-Dichlorophenyl)-3-(tetrahydro-furan-2-yl)-propionyl)-3- methylurea; antidiabetic agents; increase the flux of glucose metabolism in beta-cells and hepatocytes
12/04/2003US20030225276 Prostaglandin endoperoxide H synthase biosynthesis inhibitors
12/04/2003US20030225271 Compounds useful as reversible inhibitors of cysteine proteases
12/04/2003US20030225270 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis
12/04/2003US20030225269 Inhibitors of interleukin-1beta converting enzyme
12/04/2003US20030225252 PNA monomer and precursor
12/04/2003US20030225192 Mxitures of 2-(2-hydroxy-4(3-butoxy-2-hydroxypropyloxy)-phenyl )-4,6-bis(2,4-dimethylphenyl)-1,3,5-triazine and hindered amine light stabilizers, used for stabilization of curable polycarbonates
12/04/2003US20030225158 Compounds that modulate PPAR activity and methods for their preparation
12/04/2003US20030225152 Such as 3-phenylaminomethylene-1,3-dihydroindol-2-one; use treating cancer, blood vessel proliferative disorders, fibrotic disorders, mesangial cell proliferative disorders and metabolic diseases
12/04/2003US20030225151 Pyrazole compositions useful as inhibitors of ERK
12/04/2003US20030225150 Method of using a COX-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia
12/04/2003US20030225148 Biological methods of use of 4-amino-3-mercapto-triazoles
12/04/2003US20030225128 For treating conditions such as erectile dysfunction, cardiovascular disorders, male or female sexual dysfunction, diabetes mellitus, and gastrointestinal disorders
12/04/2003US20030225122 2-(S)-(6-(4-fluoro-benzyloxy)-3-oxo-3,4-dihydro-1H-isoquinolin -2-yl)- propionamide for example; Alzheimer's disease or senile dementia
12/04/2003US20030225120 Dihydropyridine soft drugs, and related compositions and methods
12/04/2003US20030225106 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer
12/04/2003US20030225105 New linear cyclic ureas
12/04/2003US20030225100 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same
12/04/2003US20030225090 Oxindole derivatives
12/04/2003US20030225085 For reducing neuronal cell death in response to a traumatic event
12/04/2003US20030225082 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines
12/04/2003US20030225077 Naphthylamines used to chronic inflammatory diseases.
12/04/2003US20030225071 N-heterocyclic amides and carbamates
12/04/2003US20030225061 Protease inhibitors
12/04/2003US20030225043 Especially for inhibiting type IV collagenase
12/04/2003US20030225042 Antipicornaviral compounds and compositions, their uses, and materials for their synthesis
12/04/2003CA2784937A1 Ccr9 inhibitors and methods of use thereof
12/04/2003CA2487073A1 Methods for using jnk inhibitors for treating or preventing disease-related wasting
12/04/2003CA2486962A1 Compounds
12/04/2003CA2486564A1 Acetamides and benzamides that are useful in treating sexual dysfunction
12/04/2003CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/03/2003EP1367058A1 Tetrahydropyran derivatives
12/03/2003EP1367056A1 Drugs that enhance synaptic responses mediated by AMPA receptors
12/03/2003EP1366042A1 Process to produce paroxetine
1 ... 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 ... 694